Bank of Nova Scotia’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,265
Closed -$513K 1081
2024
Q3
$513K Buy
6,265
+1,812
+41% +$140K ﹤0.01% 832
2024
Q2
$384K Buy
4,453
+462
+12% +$37.3K ﹤0.01% 869
2024
Q1
$326K Sell
3,991
-1,922
-33% -$150K ﹤0.01% 914
2023
Q4
$392K Sell
5,913
-560
-9% -$38.8K ﹤0.01% 901
2023
Q3
$473K Sell
6,473
-2,802
-30% -$189K ﹤0.01% 799
2023
Q2
$586K Buy
9,275
+1,142
+14% +$66.2K ﹤0.01% 769
2023
Q1
$477K Buy
8,133
+2,906
+56% +$176K ﹤0.01% 856
2022
Q4
$322K Sell
5,227
-7,319
-58% -$492K ﹤0.01% 995
2022
Q3
$842K Buy
12,546
+1,404
+13% +$88.9K ﹤0.01% 827
2022
Q2
$684K Sell
11,142
-1,512
-12% -$96.8K ﹤0.01% 948
2022
Q1
$853K Buy
+12,654
New +$683K ﹤0.01% 939

Other funds holding HQY

Bank of Nova Scotia's HQY Position: Q4 2024 in Review

Bank of Nova Scotia sold out of HealthEquity (HQY) in Q4 2024, closing a stake of 6,265 shares — an estimated $513K sold.

Bank of Nova Scotia first reported a position in HQY in Q1 2022 and held it in 11 quarters. The position peaked at $853K in Q1 2022. 441 funds tracked by Wall St. Rank hold HQY as of Q4 2024.

  • Bank of Nova Scotia reported no remaining HealthEquity position as of Q4 2024 after selling out during the quarter.
  • Bank of Nova Scotia sold 6,265 HealthEquity shares in Q4 2024, an estimated $513K.
  • Bank of Nova Scotia first reported a position in HealthEquity in Q1 2022 and held it in 11 quarters.
  • Bank of Nova Scotia's HealthEquity position peaked at $853K in Q1 2022.
  • 441 funds tracked by Wall St. Rank held HealthEquity as of Q4 2024.

Based on Bank of Nova Scotia's 13F filing for Q4 2024, filed 13 Feb 2025.